招募免疫对抗结直肠癌：现状与挑战

Cancer immunotherapies have changed the landscape of cancer management and improved the standard treatment protocols used in multiple tumors. This has led to significant improvements in progression-free survival and overall survival rates. In this review article, we provide an insight into the major immunotherapeutic methods that are currently under investigation for colorectal cancer (CRC) and their clinical implementations.

We emphasize therapies that are based on monoclonal antibodies (mAbs) and adoptive cell therapy, their mechanisms of action, their advantages, and their potential in combination therapy.

We also highlight the clinical trials that have demonstrated both the therapeutic efficacy and the toxicities associated with each method.

In addition, we summarize emerging targets that are now being evaluated as potential interventions for CRC.

Finally, we discuss current challenges and future direction for the cancer immunotherapy field.